Pena J M, Aulesa C, Viñas O, Bosch J, Farriol M, Schwartz S
Rev Esp Fisiol. 1983 Mar;39(1):39-44.
In an attempt to investigate the role of the lipidic emulsion Intralipid in the development of metabolic encephalopathy in a patient showing high free tryptophan levels, the relationship between lipidic emulsion and free tryptophan was examined in in vitro experiments. The addition of intralipid to normal serum produces an immediate increase in non-esterified fatty acids and a parallel rise in free tryptophan. Moreover, when serum with intralipid is incubated at 37 degrees C, the lipases release new non-esterified fatty acids and the free tryptophan increases proportionally. The non-esterified fatty acid content of intralipid was found to be 12 +/- 2 mEq X 1(-1). An inverse correlation was seen between free tryptophan and different serum albumin concentrations. It is concluded that intralipid causes an increase in free tryptophan levels. It is known that in vivo free tryptophan modulates 5-hydroxytryptamine synthesis and thus may be considered a possible causal agent for encephalopathy.
为了研究脂质乳剂英脱利匹特在一名游离色氨酸水平较高患者的代谢性脑病发展中的作用,在体外实验中检测了脂质乳剂与游离色氨酸之间的关系。向正常血清中添加英脱利匹特会使非酯化脂肪酸立即增加,同时游离色氨酸也会平行升高。此外,当含有英脱利匹特的血清在37℃孵育时,脂肪酶会释放出新的非酯化脂肪酸,游离色氨酸也会相应增加。发现英脱利匹特的非酯化脂肪酸含量为12±2 mEq×1(-1)。游离色氨酸与不同血清白蛋白浓度之间呈负相关。得出的结论是,英脱利匹特会导致游离色氨酸水平升高。众所周知,体内游离色氨酸可调节5-羟色胺的合成,因此可能被认为是脑病的一个可能病因。